Food News and Research

RSS

Research: People with chronic diseases are more likely to be food insecure

Research findings provide direct evidence that people with chronic diseases are more likely to be food insecure - that is suffering from inadequate, insecure access to food as a result of financial constraints.

30 Aug 2013

Study reveals zinc-regulated small compound in blood mediates harmful effects of zinc deprivation

According to new research published in The FASEB Journal, a drop in blood zinc levels does not directly harm the blood vessel cells. Rather, zinc regulates the production of a small molecular compound, which then circulates in the blood and causes harmful blood vessel cell effects.

30 Aug 2013

Researchers identify and track strains of antibiotic resistant salmonella

Continuing research on Salmonella may enable researchers to identify and track strains of antibiotic resistant bacteria as they evolve and spread, according to researchers in Penn State's College of Agricultural Sciences.

30 Aug 2013

Study explains how sensory input impacts fruit flies' decisions about sweet taste

Fruit flies have a lot to teach us about the complexity of food. Like these tiny little creatures, most animals are attracted to sugar but are deterred from eating it when bitter compounds are added.

29 Aug 2013

Mallinckrodt to present MNK-795 clinical data at PAINWeek 2013

Mallinckrodt announced today that the first clinical data on MNK-795 will be presented at PAINWeek 2013, to be held September 4-7 in Las Vegas. MNK-795 is an extended-release oral formulation of oxycodone and acetaminophen that has been studied in clinical trials for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.

29 Aug 2013

FDA approves NDA filing for ibrutinib inhibitor in two B-cell malignancies

Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, for two B-cell malignancy indications: previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

29 Aug 2013

Fast food TV commercials aimed at children did not comply with self-imposed guidelines

Fast food TV commercials aimed at children 2-11 years old did not comply with self-imposed guidelines organized through the Better Business Bureau (BBB) during a one-year study period, according to Dartmouth researchers who published their findings today with PLOS ONE.

29 Aug 2013

People with bacterial species in intestines are more likely to develop diabetes

The international consortium MetaHIT, which includes the research group of Jeroen Raes (VIB / Vrije Universiteit Brussel), publishes in the leading journal Nature that there is a link between richness of bacterial species in the intestines and the susceptibility for medical complications related to obesity.

29 Aug 2013

Barber pole worm genome provides essential platform to understand drug resistance in worms

Researchers have identified five enzymes that are essential to the survival of a parasitic worm that infects livestock worldwide and is a great threat to global food security. Two of these proteins are already being studied as potential drug targets against other pathogens.

29 Aug 2013

New research focuses on perfectionism to improve treatment for adolescent anorexia

Reducing ‘perfectionistic’ thinking as a way to improve treatment for adolescent anorexia, is the focus of new research by Griffith University.

28 Aug 2013

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Cepheid today announced the U.S. Food & Drug Administration has categorized Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments.

28 Aug 2013

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.

28 Aug 2013

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center G-ttingen and Chronix Biomedical, a molecular diagnostics company, the new method uses Bio-Rad Laboratories' Droplet Digital PCR (ddPCR-) technology to overcome the obstacles of earlier tests, which were both time-consuming and costly.

28 Aug 2013

Fluoride added to water supplies reduces tooth decay in children

Fluoride is a naturally occurring mineral in water and many foods. In addition, fluoride is intentionally added to the public water supplies, because it has been demonstrated that communities with fluoride added to their water supplies have significantly reduced incidence of tooth decay in children.

28 Aug 2013

UW researchers perform first noninvasive human-to-human brain interface

University of Washington researchers have performed what they believe is the first noninvasive human-to-human brain interface, with one researcher able to send a brain signal via the Internet to control the hand motions of a fellow researcher.

28 Aug 2013

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

27 Aug 2013

Intracerebral injection of BSC may reduce post-stroke cognitive dysfunction

Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored.

27 Aug 2013

Bioactive compounds in coffee may prevent prostate cancer recurrence, delay progression

Coffee consumption is associated with a lower risk of prostate cancer recurrence and progression, according to a new study by Fred Hutchinson Cancer Research Center scientists that is online ahead of print in Cancer Causes & Control.

27 Aug 2013

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.

27 Aug 2013

Study: Structural defect in skin cells can contribute to allergy development

In a new study published in Nature Genetics, Northwestern Medicine and Tel Aviv University scientists have found that a structural defect in skin cells can contribute to allergy development, including skin and food allergies, traditionally thought primarily to be a dysfunction of the immune system.

27 Aug 2013

Food News and Research

Research: People with chronic diseases are more likely to be food insecure

Study reveals zinc-regulated small compound in blood mediates harmful effects of zinc deprivation

Researchers identify and track strains of antibiotic resistant salmonella

Study explains how sensory input impacts fruit flies' decisions about sweet taste

Mallinckrodt to present MNK-795 clinical data at PAINWeek 2013

FDA approves NDA filing for ibrutinib inhibitor in two B-cell malignancies

Fast food TV commercials aimed at children did not comply with self-imposed guidelines

People with bacterial species in intestines are more likely to develop diabetes

Barber pole worm genome provides essential platform to understand drug resistance in worms

New research focuses on perfectionism to improve treatment for adolescent anorexia

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

Fluoride added to water supplies reduces tooth decay in children

UW researchers perform first noninvasive human-to-human brain interface

FDA grants Priority Review designation to sNDA for Nexavar tablets

Intracerebral injection of BSC may reduce post-stroke cognitive dysfunction

Bioactive compounds in coffee may prevent prostate cancer recurrence, delay progression

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Study: Structural defect in skin cells can contribute to allergy development

Enhancing confidence in chemical ionization spectrometry data eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News